Literature DB >> 19525926

Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis.

Ana Mozos1, Hongtao Ye, Wen-Yu Chuang, Jan-Show Chu, Wan-Ting Huang, Han-Ku Chen, Yung-Hsiang Hsu, Chris M Bacon, Ming-Qing Du, Elias Campo, Shih-Sung Chuang.   

Abstract

Primary adrenal lymphoma is extremely rare, accounting for <1% of non-Hodgkin lymphomas, and lymphoma-associated chromosomal translocations have yet to be reported in this entity. We performed a retrospective study of 10 cases in immunocompetent patients including 4 males and 6 females with a median age of 68 years. The most common presenting symptoms were abdominal pain and fever; unexpectedly, clinically evident adrenal insufficiency was detected only in one patient. The mean tumor size at diagnosis was 8.5 cm. Half of the patients had bilateral involvement. All cases presented with stage IE disease without regional nodal involvement. Histologically, eight cases were diffuse large B-cell lymphoma, all of which carried a non-germinal center B-cell phenotype. Fluorescence in situ hybridization revealed BCL6 gene rearrangement in 5 (83%) of 6 diffuse large B-cell lymphomas investigated. The remaining cases were one case each of plasmablastic lymphoma and extranodal NK/T-cell lymphoma, nasal type, the first and third case of primary adrenal lymphoma of these particular lymphoma subtypes in the English literature, respectively. At a median follow-up of 4.5 months, 7 patients died of lymphoma, 1 died of an unrelated disease, 1 was alive with disease, and 1 was alive without disease. The prognosis of these patients was poor as compared with those with nodal diffuse large B-cell lymphoma. We speculate that the poor outcome of primary adrenal lymphoma might be related to the bulky tumor size at presentation, non-germinal center B-cell phenotype, and frequent BCL-6 gene rearrangement.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19525926     DOI: 10.1038/modpathol.2009.87

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  28 in total

1.  Bilateral primary adrenal diffuse large B cell lymphoma without adrenal insufficiency: A case report and review of the literature.

Authors:  Peijie Chen; Lu Jin; Yu Yang; Liangchao Ni; Shangqi Yang; Yongqing Lai
Journal:  Mol Clin Oncol       Date:  2017-05-17

2.  Primary adrenal diffuse large B cell lymphoma: a clinicopathological and molecular study from China.

Authors:  Jing Zhang; Jian Sun; Jun Feng; Yufeng Luo; Qing Ling; Shafei Wu; Xuan Zeng; Zhiyong Liang
Journal:  Virchows Arch       Date:  2018-05-25       Impact factor: 4.064

Review 3.  Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.

Authors:  Alfred King-Yin Lam
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

Review 4.  Cross-sectional imaging features of unusual adrenal lesions: a radiopathological correlation.

Authors:  Ali Devrim Karaosmanoglu; Omer Onder; Can Berk Leblebici; Cenk Sokmensuer; Deniz Akata; Mustafa Nasuh Ozmen; Musturay Karcaaltincaba
Journal:  Abdom Radiol (NY)       Date:  2021-03-18

5.  Mantle cell lymphoma presenting as bilateral adrenal huge masses.

Authors:  Abtin Doroudinia; Mehrdad Bakhshayesh Karam; Mostafa Ranjbar; Arash Nikmanesh; Payam Mehrian
Journal:  BMJ Case Rep       Date:  2018-04-17

6.  Adrenal tumours: how to establish malignancy.

Authors:  Vanita Toogood; Sam Milliken; Adrienne Morey; Katherine Samaras
Journal:  BMJ Case Rep       Date:  2014-12-23

7.  Primary Non Hodgkin's Lymphoma of Left Adrenal Gland - A Rare Presentation.

Authors:  Anil Khurana; Paramjeet Kaur; Ashok K Chauhan; Sant Parkash Kataria; Nupur Bansal
Journal:  J Clin Diagn Res       Date:  2015-04-01

8.  New developments in the pathology of malignant lymphoma: a review of the literature published from January to August 2009.

Authors:  J Han van Krieken
Journal:  J Hematop       Date:  2009-09-26       Impact factor: 0.196

9.  Prognostic factors in primary diffuse large B-cell lymphoma of adrenal gland treated with rituximab-CHOP chemotherapy from the Consortium for Improving Survival of Lymphoma (CISL).

Authors:  Yu Ri Kim; Jin Seok Kim; Yoo Hong Min; Dok Hyunyoon; Ho-Jin Shin; Yeung-Chul Mun; Yong Park; Young Rok Do; Seong Hyun Jeong; Joon Seong Park; Sung Yong Oh; Suee Lee; Eun Kyung Park; Joung-Soon Jang; Won-Sik Lee; Hwe-Won Lee; Hyeonseok Eom; Jae-Sook Ahn; Jae-Heon Jeong; Sun Kyung Baek; Seok Jin Kim; Won Seog Kim; Cheolwon Suh
Journal:  J Hematol Oncol       Date:  2012-08-13       Impact factor: 17.388

10.  Clinicopathological analysis of primary adrenal diffuse large B-cell lymphoma: effectiveness of rituximab-containing chemotherapy including central nervous system prophylaxis.

Authors:  Satoshi Ichikawa; Noriko Fukuhara; Ai Inoue; Hiroki Katsushima; Rie Ohba; Yuna Katsuoka; Yasushi Onishi; Joji Yamamoto; Osamu Sasaki; Jun Nomura; Osamu Fukuhara; Kenichi Ishizawa; Ryo Ichinohasama; Hideo Harigae
Journal:  Exp Hematol Oncol       Date:  2013-08-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.